
ACT Brief: China’s Startup Timelines, AI-Drafted Clinical Study Reports, and Bimzelx Psoriatic Arthritis Data
11/10/2026
0:00
1:47
In today’s ACT Brief, we examine how China’s trial startup timelines compare with those in the US and Europe, whether AI-drafted clinical study reports speed drug development, and how Bimzelx compared with Skyrizi in psoriatic arthritis.
More episodes from "Applied Clinical Trials"



Don't miss an episode of “Applied Clinical Trials” and subscribe to it in the GetPodcast app.








